A large government study published Thursday shows more definitively than ever before that Americans’ self-reported race is a ...

This week on "The Readout LOUD" podcast: an AI experiment at the FDA and how Novo Nordisk is trailing in the obesity drug ...

With millions of people at risk of losing health insurance under Trump’s tax bill, lawmakers have begun lobbying the ...

A study shows levels of the amino acid taurine rise rather than fall over time, confounding the goal of dietary supplements ...

While overall risk of macular degeneration remained low, a study suggests that GLP-1 drugs may have increased that risk in ...

The rewriting of government recommendations will make the effort to get vaccine doses into arms exponentially more difficult, ...

The former workers cited various reasons why they think Novo was cautious: its conservative culture and history of investing ...

And it’s never a bad time to re-read some of the team’s excellent, award-winning coverage on the company: Last week, key ...

Exclusive: OpenEvidence aims to be ‘Disney+’ with new JAMA deal. OpenEvidence this morning announced it has a new multi-year ...

In the late 2010s, Novo Nordisk shelved a weekly obesity treatment that targeted three hormones at once, though it caused notable weight loss in mice ...

MoonLake Immunotherapeutics is for sale? This sounds like a cry for help, STAT's Adam Feuerstein writes.

The NIH archives of the Human Genome Project could fall victim to Trump administration cuts, writes a former archivist.